We are live on ! Find out more
EI

EAM Investors Portfolio holdings

AUM $866M
1-Year Est. Return 377.14%
This Fund
S&P 500
This Quarter Est. Return
+25.31%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.07%
10 Year Est. Return
+19,957,621.5%
AUM
$615M
AUM Growth
-$26.4M
Cap. Flow
-$90.4M
Cap. Flow %
-14.7%
Top 10 Hldgs %
10.02%
Holding
357
New
126
Increased
9
Reduced
90
Closed
116

Top Buys

Rank Stock Value
1
FTAI icon
FTAI Aviation
FTAI
+$5.42M
2
CBT icon
Cabot Corp
CBT
+$4.61M
3
BCO icon
Brink's
BCO
+$4.45M
4
FORM icon
FormFactor
FORM
+$4.43M
5
BMI icon
Badger Meter
BMI
+$4.35M

Sector Composition

Rank Sector Weight
1 Industrials 26.41%
2 Technology 22.84%
3 Healthcare 18.79%
4 Consumer Discretionary 10.92%
5 Financials 7.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APGE icon
251
Apogee Therapeutics
APGE
$10.2B
-55,113
Closed -$3.66M
APLT
252
DELISTED
Applied Therapeutics
APLT
-92,872
Closed -$632K
AQST icon
253
Aquestive Therapeutics
AQST
$492M
-108,244
Closed -$461K
AROC icon
254
Archrock
AROC
$5.84B
-203,400
Closed -$4M
AWI icon
255
Armstrong World Industries
AWI
$7.78B
-32,820
Closed -$4.08M
AXTI icon
256
AXT Inc
AXTI
$4.92B
-200,495
Closed -$920K
AYI icon
257
Acuity Brands
AYI
$10.7B
-15,199
Closed -$4.08M
AZEK
258
DELISTED
The AZEK Co
AZEK
-81,064
Closed -$4.07M
BAND
259
Bandwidth Inc
BAND
$1.44B
-56,566
Closed -$1.03M
BASE
260
DELISTED
Couchbase
BASE
-139,261
Closed -$3.66M
BHVN icon
261
Biohaven
BHVN
$2.17B
-58,364
Closed -$3.19M
BLZE icon
262
Backblaze
BLZE
$1.12B
-106,817
Closed -$1.09M
BWMN icon
263
Bowman Consulting
BWMN
$472M
-25,463
Closed -$886K
BWXT icon
264
BWX Technologies
BWXT
$15.3B
-39,869
Closed -$4.09M
CAL icon
265
Caleres
CAL
$486M
-93,804
Closed -$3.85M
CDXS icon
266
Codexis
CDXS
$159M
-199,474
Closed -$696K
CLDX icon
267
Celldex Therapeutics
CLDX
$3.26B
-70,115
Closed -$2.94M
CLMB icon
268
Climb Global Solutions
CLMB
$513M
-49,624
Closed -$879K
CNM icon
269
Core & Main
CNM
$8.52B
-74,486
Closed -$4.26M
COLL icon
270
Collegium Pharmaceutical
COLL
$944M
-79,949
Closed -$3.1M
CRDF icon
271
Cardiff Oncology
CRDF
$74.7M
-161,903
Closed -$865K
CVCO icon
272
Cavco Industries
CVCO
$4.45B
-11,050
Closed -$4.41M
CXDO icon
273
Crexendo
CXDO
$216M
-181,506
Closed -$873K
CYBR
274
DELISTED
CyberArk
CYBR
-5,425
Closed -$1.44M
CYTK icon
275
Cytokinetics
CYTK
$11B
-40,625
Closed -$2.85M

Similar funds

EAM Investors's Q2 2024 Portfolio in Review

As of Q2 2024, EAM Investors held 357 positions worth $615M, down 4.1% from $642M the previous quarter. Its ten largest holdings account for 10% of the portfolio.

EAM Investors withdrew a net $90.4M in Q2 2024, closing 116 positions and reducing 90 holdings. Its most notable exit was Viking Therapeutics, an estimated $5.99M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 26% of assets, up from 26% a quarter earlier, followed by Technology and Healthcare.

Against the trend, EAM Investors opened a new position in FTAI Aviation worth $7.04M.

  • EAM Investors's largest Q2 2024 buy was FTAI Aviation: 68,171 shares worth $7.04M.
  • EAM Investors added most to American Superconductor in Q2 2024, an estimated $2.33M increase.
  • EAM Investors's biggest Q2 2024 reduction was Super Micro Computer, cutting an estimated $5.21M.
  • EAM Investors fully exited Viking Therapeutics in Q2 2024, selling an estimated $5.99M.
  • EAM Investors's ten largest holdings make up 10% of its $615M portfolio in Q2 2024.
  • EAM Investors opened 126 new positions and closed 116 in Q2 2024.
  • EAM Investors's portfolio value fell 4.1% quarter-over-quarter to $615M.

Based on EAM Investors's 13F filing for Q2 2024, filed 12 Aug 2024.